InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Sullivan Timothy Eugene, Chief Financial Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 9 filings have been logged. The latest transaction was filed on 10 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
140,945 shares
Common Stock
SEC:0001193125-26-224615·
140,945 shares
Common Stock
SEC:0001193125-26-224615:0·
€36,099875 shares@ €41.25540.0007% mcap4.9% of flow
Common Stock
SEC:0001127602-22-004779:0·
€22,502650 shares@ €34.61910.0004% mcap6.4% of flow
Common Stock
SEC:0001127602-22-002810·
€22,502650 shares@ €34.61910.0004% mcap3.0% of flow
Common Stock
SEC:0001127602-22-002810:0·
030,787 shares0
Common Stock
SEC:0001127602-22-002068·
030,787 shares0
Common Stock
SEC:0001127602-22-002068:0·
€328,59739,880 shares@ €8.23960.0063% mcap93.6% of flow
Common Stock
SEC:0001127602-21-019510·
€328,59739,880 shares@ €8.23960.0063% mcap44.5% of flow
Common Stock
SEC:0001127602-21-019510:0·
9 of 9 declarations
About Sullivan Timothy Eugene
Timothy Eugene Sullivan is the Chief Financial Officer at Apellis Pharmaceuticals, Inc. He is responsible for financial management and strategy for the company. Sullivan plays a key role in optimizing financial processes and implementing strategies aimed at improving Apellis' financial performance.
